Filed with the SEC on · accession 0001493152-26-044007
LTRN filed a 8-K (current report) with the SEC on Sep 24, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -12.9% by the first close after the filing.
Lantern Pharma hosted a live webinar on September 23, 2026 to discuss its Open-Medicine AI multi-agentic platform for drug development, furnishing the presentation as Exhibit 99.1 under Regulation FD.
Close before
$1.39
Sep 23, 2026
First close after
-12.95%
$1.21
5 trading days
-27.34%
$1.01
Since filing
-59.14%
$0.57
✦ Ask GOAX AI about this filing — what it means for LTRN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LTRN?
Click hereLTRN filed a 8-K (SEC filing). Lantern Pharma hosted a live webinar on September 23, 2026 to discuss its Open-Medicine AI multi-agentic platform for drug development, furnishing the presentation as Exhibit 99.1 under Regulation FD.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
LTRN closed at $1.39 before the filing and $1.21 on Sep 24, 2026 (-12.95%). Five trading days later: $1.01 (-27.34%).
Get alerts when LTRN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days